Michael D. Carroll is a Newsweek Breaking News Editor based in Birmingham, United Kingdom. His focus is reporting live news, U.S. and U.K. politics, and world news with attention on the Middle ...
AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...